Interim Chief Medical Officer Support

Boyds was established 19 years ago and has a proven track record in strategic drug development. We provide clinical and medical support for all stages of drug development. Dr Karen Mullen, Chief Medical Officer at Boyds, leads a team of specialized pharmaceutical physicians who have extensive expertise in the clinical development of pharmaceutical and biological products across all therapy areas.

We understand the challenge of finding the right in-house CMO. We offer a flexible, cost-effective solution to help meet your needs and bridge the gap, whether you’re seeking a permanent hire or don’t yet need a full-time CMO. Boyds’ interim CMOs balance leadership with operational delivery providing technical and medical expertise.

An overview of Boyds’ Interim CMO services:

• Development of a clinical development plan aligned with a comprehensive regulatory strategy
• Development of clinical trial protocols, combined with clinical trial oversight
• Developing and executing a medical strategy including publication planning, scientific messaging, engaging with external experts and patient groups, analysing competitor landscapes
• Providing regulatory support with all regulatory interactions, including IND filings
• Representing your company, presenting to investors, executive boards and key stakeholders

In addition to the above, Boyds has extensive clinical operations, medical writing and regulatory experience and expertise in NCEs, drug delivery devices and biologic products.